Disruption of mitochondrial function in Candida albicans leads to reduced cellular ergosterol levels and elevated growth in the presence of amphotericin B

Archives of Microbiology

Volumn 179, Issue 4, 2003, Pages 295-300

  Geraghty, Patrick ^a   Kavanagh, Kevin ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Amphotericin B; Candida; Ergosterol; Mitochondrion

Indexed keywords

AMPHOTERICIN B; CYTOCHROME; ERGOSTEROL; ETHIDIUM BROMIDE; GLYCEROL;

ARTICLE; CANDIDA ALBICANS; CELL CULTURE; CELL DISRUPTION; CYBRID; FUNGAL CELL; GROWTH; MITOCHONDRION; MUTANT; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTOPLAST; REDUCTION; TEMPERATURE DEPENDENCE;

CANDIDA; CANDIDA ALBICANS;

EID: 0037398882     PISSN: 03028933     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00203-003-0530-y     Document Type: Article

References (28)

1. Abu-Hatab M, Whittaker PA (1992) Isolation and characterization of respiration-deficient mutants from the pathogenic yeast Candida albicans. Antonie van Leeuwenhoek 62:207-219
2. Abu- Salah K (1996) Amphotericin B: an update. Brit J Biomed Sc 53:122-133
3. Aoki S, Ito-Kuwa S (1987) Induction of petite mutation with acriflavine and elevated temperature in Candida albicans. J Med Vet Mycol 25:269-277
4. Aoki S, Ito-Kuwa S, Nakamura Y, Masuhara T (1990) Comparative pathogenicity of a wild-type strain and respiratory mutants of Candida albicans in mice. Zbl Bakt 273:332-342
5. Arthington-Skaggs BA, Wamock DW, Morrison CJ (1999) Quantitation of ergosterol content: Novel methods for determination of fluconazole susceptibility of Candida albicans. J Clin Microbiol 37:3332-3337
6. Bouchara JP, Zouhair R, Le Boudouil S, Renier G, Filmon R, Chabasse D, Hallet JN, Defontaine A (2000) In vivo selection of an azole-resistance petite mutant of Candida glabrata. J Med Microbiol 49:977-984
7. Daum G, Lees ND, Bard M, Dickson R (1998) Biochemistry, cell biology and molecular biology of lipids of Saccharomyces cerevisiae. Yeast 14:1471-1510
8. Defontaine A, Bouchara JP, Declerk P, Planchenault C, Chabasse D, Hallet JN (1999) In-vivo resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata. J Med Microbiol 48:663-670
9. Ferenczy L, Maraz A (1977) Transfer of mitochondria by protoplast fusion in Saccharomyces cerevisiae. Nature 268:524-525
10. Ferguson LR., Von Borstel RC (1992) Induction of the cytoplasmic petite mutation by chemical and physical agents in Saccharomyces cerevisiae. Mut Res 265:103-148
11. Geber A, Hitchcock CA, Swartz JE, Pullen FS, Marsden KE, Kwon-Chung KJ, Bennett JE (1995) Deletion of the Candida glabrata ERG3 and ERG 11 genes: Effect on cell viability, cell growth, sterol composition and antifungal susceptibility. Antimicrob Agents Chemother 39:2708-2717
12. Goldering, ES, Grossman LI, Krupnick D, Cryer DR, Marmur J (1970) The petite mutation in yeast: loss of mitochondrial deoxyribonucleic acid during induction of petites with ethidium bromide. J Mol Biol 52:323-335
13. Gyurko C, Lendenmann U, Troxler RF, Oppenheim FG (2000) Candida albicans mutants deficient in respiration are resistant to the small cationic salivary antimicrobial peptide histatin 5. Antimicrob Agents Chemotherap 44:348-354
14. Kavanagh K, Whittaker PA (1996) Application of protoplast fusion to the non-conventional yeast. Enz Microbiol Technol 18:45-51
15. Kavanagh K, Walsh M, Whittaker PA (1991) Enhanced intraspecific protoplast fusion in yeast. FEMS Microbiol Letts 81:283-286
16. 5,6 desaturation. FEBS Letts 400:80-82
17. Lunel FM, Meis FG, Voss A (1999) Nosocomial fungal infections: Candidemia. Diagn Microbiol Infect Dis 34:213-220
18. Maraz A, Ferenczy L (1980) Selective transfer of fungal cytoplasmic genetic elements by protoplast fusion. Curr Microbiol 4:343-345
19. Moran G, Sullivan DJ, Henman MC, McCreary CE, Harrington BJ, Shanley DB, Coleman DC (1997) Anti-fungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole resistant derivatives in vitro. Antimicrob Agents Chemotherap 41:617-623
20. Parks LW, Casey WM (1995) Physiological implications of sterol biosynthesis in yeast. Ann Rev Microbiol 49:95-116
21. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP (1998) National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and anti-fungal susceptibility in the SCOPE programme. Diagn Microbial Infect Dis 31:327-332
22. Richards MS, Van Broock MR, Figueroa LI (1987) Restoration of respiratory competence in the yeast Candida utilis after somatic fusion with Saccharomyces cerevisiae. Curr Microbiol 16:109-112
23. Sanglard D, Ischer F, Bille J (2001) Role of ATP-binding-casette transporter genes in high frequency acquisition of resistance to azole antifungals in Candida glabrata. Antimicrob Agents Chemother 45, 1174-1183
24. Spirek M, Horvath A, Piskur J, Sulo P (2000) Functional co-operation between the nuclei of Saccharomyces cerevisiae and the mitochondria from other yeast species. Curr Genet 38:202-207
25. Vazquez JA, Arganoza MT, Vaishampayan JK, Akins RA (1996) In vitro interaction between Amphotercin B and azoles in Candida albicans. Antimicrob Agents Chemother 40:2511-2516
26. White TC, Marr KA, Bowden RA (1998) Clinical, cellular and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 11:382-402
27. Whittaker PA, Danks SM (1978) Mitochondria: structure, function and assembly. Integrated Themes in Biology, Longman, London
28. Wolfger H, Mamnun YM, Kuchler K (2001) Fungal ABC proteins: pleiotropic drug resistance, stress response and cellular detoxification. Res Microbiol 152:375-389